Company Spotlight: Ever Fortune.AI APPEN-CT-100 - Flagging Appendicitis

We unpack the FDA 510(k) clearance summary for the EFAI Ersuite CT Appendicitis Assessment System. Discover how this AI triage tool performed in a 300-case retrospective study, its 3.37-minute processing time, and how its text-based notifications aim to assist emergency workflow.

Key points

• The EFAI Ersuite CT Appendicitis Assessment System is a Class II device cleared for the triage and notification of contrast-enhanced abdominal CT images.
• In a retrospective, blinded, multisite study of 300 cases, the system demonstrated a sensitivity of 0.928 and a specificity of 0.932.
• The reference standard was determined by majority agreement among three U.S. board-certified radiologists.
• The software provides passive, text-based JSON notifications without preview images and does not alter or mark the original medical image.
• Mean system processing time per case was 3.37 minutes, operating in parallel with the standard of care workflow.

Source: FDA 510(k) summary K253163: EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100) (Ever Fortune.Ai) - U.S. Food and Drug Administration, 2026

This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

Company: Ever Fortune.Ai · Product: EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100) · FDA 510(k) K253163

Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-ever-fortune-ai-appen-ct-100-flagging-appendicitis-af951b